Unknown

Dataset Information

0

VHPKQHR Peptide Modified Ultrasmall Paramagnetic Iron Oxide Nanoparticles Targeting Rheumatoid Arthritis for T1-Weighted Magnetic Resonance Imaging.


ABSTRACT: Magnetic resonance imaging (MRI) could be the ideal diagnostic modality for early rheumatoid arthritis (RA). Vascular cell adhesion molecule-1 (VCAM-1) is highly expressed in synovial locations in patients with RA, which could be a potential target protein for RA diagnosis. The peptide VHPKQHR (VHP) has a high affinity to VCAM-1. To make the contrast agent to target RA at an early stage, we used VHP and ultrasmall paramagnetic iron oxide (USPIO) to synthesize UVHP (U stands for USPIO) through a chemical reaction with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide. The size of UVHP was 6.7 nm; the potential was -27.7 mV, and the r 2/r 1 value was 1.73. Cytotoxicity assay exhibited that the cell survival rate was higher than 80% at even high concentrations of UVHP (Fe concentration 200 µg/mL), which showed the UVHP has low toxicity. Compared with no TNF-α stimulation, VCAM-1 expression was increased nearly 3-fold when mouse aortic endothelial cells (MAECs) were stimulated with 50 ng/mL TNF-α; cellular Fe uptake was increased very significantly with increasing UVHP concentration under TNF-α treatment; cellular Fe content was 17 times higher under UVHP with Fe concentration 200 µg/mL treating MAECs. These results indicate that UVHP can target overexpression of VCAM-1 at the cellular level. RA mice models were constructed with adjuvant-induced arthritis. In vivo MRI and biodistribution results show that the signal intensity of knee joints was increased significantly and Fe accumulation in RA model mice compared with normal wild-type mice after injecting UVHP 24 h. These results suggest that we have synthesized a simple, low-cost, and less toxic contrast agent UVHP, which targeted VCAM-1 for early-stage RA diagnosis and generates high contrast in T1-weighted MRI.

SUBMITTER: Zhang C 

PROVIDER: S-EPMC8918785 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

VHPKQHR Peptide Modified Ultrasmall Paramagnetic Iron Oxide Nanoparticles Targeting Rheumatoid Arthritis for T<sub>1</sub>-Weighted Magnetic Resonance Imaging.

Zhang Chunyu C   Huang Wentao W   Huang Chen C   Zhou Chengqian C   Tang Yukuan Y   Wei Wei W   Li Yongsheng Y   Tang Yukuan Y   Luo Yu Y   Zhou Quan Q   Chen Wenli W  

Frontiers in bioengineering and biotechnology 20220228


Magnetic resonance imaging (MRI) could be the ideal diagnostic modality for early rheumatoid arthritis (RA). Vascular cell adhesion molecule-1 (VCAM-1) is highly expressed in synovial locations in patients with RA, which could be a potential target protein for RA diagnosis. The peptide VHPKQHR (VHP) has a high affinity to VCAM-1. To make the contrast agent to target RA at an early stage, we used VHP and ultrasmall paramagnetic iron oxide (USPIO) to synthesize UVHP (U stands for USPIO) through a  ...[more]

Similar Datasets

| S-EPMC9610745 | biostudies-literature
| S-EPMC6774037 | biostudies-literature
| S-EPMC6199858 | biostudies-literature
| S-EPMC10150182 | biostudies-literature
| S-EPMC5302717 | biostudies-literature
| S-EPMC9338602 | biostudies-literature
| S-EPMC11497041 | biostudies-literature
| S-EPMC5592912 | biostudies-literature
| S-EPMC6943426 | biostudies-literature
| S-EPMC5318892 | biostudies-literature